Regadenoson Reduces Soluble Receptor for Advanced Glycation End-Products in Lung Recipients-Reference-Cited by-同舟云学术

Regadenoson Reduces Soluble Receptor for Advanced Glycation End-Products in Lung Recipients

Published:2023-12 Issue:6 Volume:116 Page:1150-1158
ISSN:0003-4975
Container-title:The Annals of Thoracic Surgery
language:en
Short-container-title:The Annals of Thoracic Surgery

Author:

Zhao Yunge,Dhru Urmil,Fleischmann Emily,Mostafa Ezzat,Al-Suqi Manal,Conaway Mark R.,Krupnick Alexander S.,Linden Joel,Rabin Joseph,Lau Christine L.^ORCID

Funder

NIH

US Department of Veterans Affairs

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference37 articles.

1. The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012;Christie;J Heart Lung Transplant,2012

2. Primary graft dysfunction and other selected complications of lung transplantation: a single-center experience of 983 patients;Meyers;J Thorac Cardiovasc Surg,2005

3. Pathophysiology and classification of primary graft dysfunction after lung transplantation;Morrison;J Thorac Dis,2017

4. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome;Daud;Am J Respir Crit Care Med,2007

5. Receptor for advanced glycation end products (RAGE) on iNKT cells mediates lung ischemia-reperfusion injury;Sharma;Am J Transplant,2013

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early serum biomarkers to characterise different phenotypes of primary graft dysfunction after lung transplantation: a systematic scoping review;ERJ Open Research;2024-05-23

2. Regadenoson Is All the RAGE: Targeting the Inflammatory Cascade in Primary Graft Dysfunction;The Annals of Thoracic Surgery;2023-12